Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Invitrogen Licenses Technology for Fluorescent microRNA Labeling Kits

By Labmedica staff writers
Posted on 11 Mar 2008
Using Genisphere Inc.'s (Hatfield, PA, USA) 3DNA dendrimer signal amplification technology, Invitrogen Corp. More...
(Carlsbad, CA, USA) will become the exclusive provider of fluorescent microRNA (miRNA) microarray labeling kits, according to a new license agreement. Genisphere's technology is combined with Invitrogen's Alexa Fluor fluorescent dyes and commercialized in the new NCode rapid miRNA labeling system, which is available from Invitrogen.

Genisphere's 3DNA dendrimer technology is based on highly branched DNA structures serving as scaffolds for multitudes of fluorescent dyes. As a class, dendrimers are complex, branched molecules built from interconnected natural or synthetic monomeric subunits. A 3DNA dendrimer is constructed from DNA monomers, as the name "3DNA” indicates.

Each 3DNA monomer is composed of two DNA strands that share a region of sequence complementarily located in the central portion of each strand. When the two strands anneal to form the monomer the resulting structure has a central double-stranded "waist” bordered by four single-stranded "arms.” This waist plus arms structure comprises the basic 3DNA monomer.

"Our new kit accelerates the discovery of novel miRNA biomarkers by reducing the amount of time scientists must invest to detect miRNAs. In addition, we have increased sensitivity compared to alternative technologies, which can preserve precious samples,” said Peter Welch, director of research and development, gene expression profiling at Invitrogen. "Because miRNAs play a significant role in cancer and in the differentiation of stem cells, discoveries resulting from experiments in those areas could potentially expedite the diagnostics applications of miRNA biomarkers in disease.”


Related Links:
Genisphere
Invitrogen

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.